{
    "organizations": [],
    "uuid": "b5ad1c446a3888780c07fd71756a58d3d21a2225",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kane-biotech-reports-qtrly-loss-pe/brief-kane-biotech-reports-qtrly-loss-per-share-0-011-idUSASC0A2VH",
    "ord_in_thread": 0,
    "title": "BRIEF-Kane Biotech Reports Qtrly Loss Per Share (Post Consolidation) $0.011",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Kane Biotech Inc:\n* KANE BIOTECH ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS, GRANTING OF OPTIONS AND INVESTOR RELATIONS IMPROVEMENTS\n* KANE BIOTECH INC QTRLY LOSS PER SHARE (POST CONSOLIDATION) $0.011 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-18T05:38:00.000+03:00",
    "crawled": "2018-05-18T19:29:43.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "kane",
        "biotech",
        "inc",
        "kane",
        "biotech",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "granting",
        "option",
        "investor",
        "relation",
        "improvement",
        "kane",
        "biotech",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "post",
        "consolidation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}